Amantadine ( Generic Symadine, Symmetrel )
|
USFDA Approved Medicine for the treatment of Influenzavirus A[2][3][4][5] in adults and to help reduce symptoms of Parkinson's disease and drug-induced extrapyramidal syndromes.Prevention and treatment of signs and symptoms of infection caused by various strains of influenza A virusAmantadine is effective in the treatment of active influenza A infection when administered within 48 hours after the onset of symptoms.Treatment of Parkinson's diseaseIdiopathic parkinsonism, Secondary parkinsonism (e.g. of post-encephalitic type, of cerebrovascular origin or drug-induced parkinsonism) (see Interaction with other medicinal products and other forms of interaction). Amantadine can be given alone for initial therapy or combined with anticholinergic drugs or L-dopa. |
